{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/008/ERR12766508/ERR12766508_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/010/ERR12766510/ERR12766510_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/008/ERR12766508/ERR12766508_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/006/ERR12766506/ERR12766506_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/007/ERR12766507/ERR12766507_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/004/ERR12766504/ERR12766504_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/005/ERR12766505/ERR12766505_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/011/ERR12766511/ERR12766511_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/005/ERR12766505/ERR12766505_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/011/ERR12766511/ERR12766511_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/009/ERR12766509/ERR12766509_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/003/ERR12766503/ERR12766503_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/009/ERR12766509/ERR12766509_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/004/ERR12766504/ERR12766504_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/006/ERR12766506/ERR12766506_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/003/ERR12766503/ERR12766503_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/007/ERR12766507/ERR12766507_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR127/010/ERR12766510/ERR12766510_2.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["European Bioinformatics Institute","Center for Oncological Research and Integrated Personalised Precision Oncology Network - Antwerp University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJEB74062"],"broker_name":["ArrayExpress"],"long_description":["In this experiment, SUM149 IBC cells were cultured using baseline medium (N=3), and in baseline medium supplemented with increasing concentration of Lapatinib to induce resistance (N=3 rSUM149). Resistant reversal SUM149 cells (rrSUM149) were then generated by culturing in rSUM149 cells in baseline medium. Gene expression data were generated to identify differentially expressed genes, as well as differentially activated proteins and pathways during Lapatinib resistance and resistance reversal. Gene expression were also integrated with proteome expression data generated under the same conditions."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"RNA-sequencing of treatment-naive, Lapatinib-resistant, and resistant-reversal SUM149 IBC cells","description":"RNA-sequencing of treatment-naive, Lapatinib-resistant, and resistant-reversal SUM149 IBC cells","dates":{"last_updated":"2024-04-05","first_public":"2024-04-05"},"accession":"PRJEB74062","cross_references":{}}